These findings support a model in which p62 sequesters DCLK1 isoforms, shielding them from degradation and promoting their accumulation in the tumor microenvironment—potentially enhancing stemness, immune evasion, and tumor progression. This evidence concerns the gene DCLK1 and neoplasm.